Skip to main content
OpenTrials
Completed

NCT Number: NCT05690516

The Protective Effect of Mask Wearing Against Respiratory Tract Infections

In this trial the researchers plan to recruit 4,000 volunteers to be randomly allocated either wearing face masks in public spaces where they are close to other people, or not wear face masks in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about whether they experienced the common cold, influenzas or COVID-19 symptoms during the trail period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Norwegian Institute of Public Health

Oslo, 0213, Norway

About this study

This study is a pragmatic, two-armed cluster randomized superiority trial including participants in Norway. Participants will be randomized to one of the following two arms: control group or medical masks in a 1:1 ratio. The primary outcome is self-reported respiratory infection.

The intervention is to ask participants in the intervention groups to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. The control group will be asked not to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. Participants will continue to use, or not use, face masks at work independent of which group they are allocated to.

The trial will be fully remote and without any personal interaction between investigators and participants.

The researchers aim to include about 4,000 participants to have a statistical power of 80% to detect a relative risk reduction of 30% for the primary outcome.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are at least 18 years of age
  • Are willing to be randomized to wear, or not to wear, face masks outside their home when close to others for a 14-day period
  • Provide informed consent

Exclusion criteria

  • None

Treatment and study plan

Wearing face masks

Behavioral

Participants are asked to wear face masks in public spaces.

Primary outcomes

  1. Respiratory symptoms of the common cold, influenza or COVID-19

    Time frame: Day 1 to 17

    Self-report

Secondary outcomes

  1. Covid-19 prevalence

    Time frame: Day 1 to 17

    Self-report

  2. Positive test for SARS-CoV-2

    Time frame: Day 3 to 17 after start of tiral period

    We will compare the incidence of notified cases of COVID-19 (i.e. registered positive SARS-CoV-tests)

  3. Health care use for respiratory symptoms

    Time frame: Day 1 to 17

    Self-report

  4. Health care use for injuries

    Time frame: Day 1 to 17

    Self-report

  5. Health care use (all causes)

    Time frame: Day 1 to 17

    Self-report

Sponsors and collaborators

Lead sponsor

Norwegian Institute of Public Health

Other Gov

Collaborators

  • University of Basel

Registry information

Official study title

The Protective Effect of Mask Wearing Against Respiratory Tract Infections: a Pragmatic Randomized Trial

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jan 19, 2023
Registry last updated
Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.